LAWSUITS FILED AGAINST ZEV, Z and NVAX - Jakubowitz Law Pursues Shareholders Claims
November 19, 2021 at 10:00 AM EST
NEW YORK, NY / ACCESSWIRE / November 19, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Lightning Emotors, Inc (NYSE:ZEV)
CONTACT JAKUBOWITZ ABOUT ZEV:
Class Period: May 7, 2021 - August 16, 2021
Lead Plaintiff Deadline: December 15, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company would record a substantially greater net loss per share in the second quarter of 2021 compared to the second quarter of 2020 and would pull its full year guidance for the remainder of 2021; (ii) accordingly, the Company materially overstated its financial position and/or prospects; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Zillow Group, Inc. (NASDAQ:Z)
CONTACT JAKUBOWITZ ABOUT Z:
Class Period : February 10, 2021 - November 2, 2021
Lead Plaintiff Deadline: January 18, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) despite operational improvements, the Company experienced significant unpredictability in forecasting home prices for its Zillow Offers business; (2) such unpredictability, as well as labor and supply shortages, led to a backlog of inventory; (3) as a result of the foregoing, the Company was reasonably likely to wind-down its Zillow Offers business, which would have a material adverse impact on its financial results; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Novavax, Inc. (NASDAQ:NVAX)
CONTACT JAKUBOWITZ ABOUT NVAX:
Class Period : March 2, 2021 - October 19, 2021
Lead Plaintiff Deadline: January 11, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Novavax overstated its manufacturing capabilities and downplayed manufacturing issues that would impact its approval timeline for NVX-CoV2373, a protein-based vaccine candidate engineered from the genetic sequence of the first strain of the SARS-CoV-2 coronavirus; (ii) as a result, Novavax was unlikely to meet its anticipated Emergency Use Authorization regulatory timelines for NVX-CoV2373; (iii) accordingly, the Company overstated the regulatory and commercial prospects for NVX-CoV2373; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Jakubowitz Law
View source version on accesswire.com: